                         SEQUENCE LISTING

<110>  Intarcia Therapeutics, Inc.
 
<120>  COMPOSITIONS, DEVICES AND METHODS OF USE THEREOF FOR THE 
       TREATMENT OF CANCERS

<130>  INT 030.30

<140>  PCT/US2012/025140
<141>  2012-02-14

<150>  61/443,628
<151>  2011-02-16

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  1

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  2
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide sequence, exenatide, having the exendin-4 
       polypeptide sequence from Heloderma suspectum

<400>  2

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


